Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MAN1A1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA562757
Description
Immunogen sequence: TLQKLPEEIQ RDILLEKKKV AQDQLRDKAP FRGLPPVDFV PPIGVESREP ADAAIREK Highest antigen sequence identity to the following orthologs: Mouse - 86%, Rat - 86%.
This gene encodes a class I mammalian Golgi 1,2-mannosidase which is a type II transmembrane protein. This protein catalyzes the hydrolysis of three terminal mannose residues from peptide-bound Man(9)-GlcNAc(2) oligosaccharides and belongs to family 47 of glycosyl hydrolases.
Specifications
MAN1A1 | |
Polyclonal | |
Unconjugated | |
MAN1A1 | |
Aa2-166; Alpha-1,2-mannosidase IA; HUMM3; HUMM9; Man(9)-alpha-mannosidase; Man1a; MAN1A1; MAN9; Man9-mannosidase; mannosidase 1, alpha; mannosidase alpha class 1A member 1; mannosidase, alpha, class 1A, member 1; mannosyl-oligosaccharide 1,2-alpha-mannosidase 1A; mannosyl-oligosaccharide 1,2-alpha-mannosidase IA; mannosyl-oligosaccharide 1,2-alpha-mannosidase IA; LOW QUALITY PROTEIN: mannosyl-oligosaccharide 1,2-alpha-mannosidase IA; mannosyl-oligosaccharide 1,2-alpha-mannosidase IA-like; mannosyl-oligosaccharide alpha-1,2-mannosidase; PCR1; processing alpha-1,2-mannosidase IA; si:dkey-164k19.1; si:dkeyp-6c7.1 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
4121 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.4 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P33908 | |
MAN1A1 | |
Recombinant protein corresponding to Human MAN1A1. Recombinant protein control fragment (Product #RP-103148). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction